Workday appoints Wayne A.I. Frederick, M.D. to board of directors

Workday, Inc.

Dr. Frederick is president of Howard University (since July 2014) and brings experience in higher education and healthcare.
He receives a one-time RSU grant of $750,000, vesting one-fourth on July 15, 2023, then quarterly over 12 quarters.
He also receives an annual RSU grant of $320,000 under the non-employee director compensation program, vesting on May 15 of the following year.
Board determined Dr. Frederick is independent per Nasdaq rules; Howard University paid Workday $4,032,636 in FY2022 as an arms-length customer.
Dr. Frederick serves on boards of Forma Therapeutics, Humana, Insulet, and Mutual of America.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Wayne A. I. Frederick, M.D.

Class II director

WDAY · Workday, Inc.

Effective: 2022-06-22
Filed: June 22, 2022, 7:59 PM ET

On and effective June 22, 2022, the Board of Directors (the “Board”) of Workday, Inc. (“Workday”) appointed Wayne A. I. Frederick, M.D. as a Class II director

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Wayne A. I. Frederick, M.D. was appointed as Class II director at Workday, Inc..

Action: appointed
Role: Class II director

Exact text from the filing

On and effective June 22, 2022, the Board of Directors (the “Board”) of Workday, Inc. (“Workday”) appointed Wayne A. I. Frederick, M.D. as a Class II director

View on SEC.gov

Workday, Inc. filing history →

Source: SEC EDGAR

accession 0001327811-22-000112

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.